Rise of the Tweetorial

One of the interesting developments in MedTwitter has been the chained tweet to demonstrate a point. I think the master of this is Professor Darrel Francis.

This one is nicely relevant to this week’s NephJC:

Another famous innovator of the Medical Tweetorial is Vinay Prasad. Vinay smartly collects the first tweet to his Tweetorials in a pinned tweet.

Another master of the Tweetorial is Tony Breu. He, similarly, collected his Tweetorials in one place.

This one has relevance to nephrology. Brilliant explanation.

Speaking of relevance to nephrology, Swapnil has thrown his hat in the Tweetorial ring

Paul Sufka has joined the party focusing with a focus on rheumatology:

Here is Bryan Vartebedian’s take on this development. His problems with the rise of the tweetorial can be summed as:

  • Poor indexing and search means these tweetorials will not be able to be found later.
  • Using 280 character tweets to convey 500-word ideas is a mismatch between the medium and message. These ideas would be better conveyed in a blog post rather than chopped up into beads of text to be strung together.
  • MedTwitter is a just a small sliver of the medical community and doing tweetorials traps the ideas in this small box.

In his conclusion, Vartabedian hedges a bit, but it is clear he believes in the blog:

I firmly believe that all of us should be poking at these applications to discover their most creative uses. But what any of us think is less relevant than what sticks with the public community of physicians. The market will bear this one out.

I love Sufka’s lessons on ANA. Prasay’s thread is a bold call to action that challenges the medical industrial publishing complex. It’s an important reminder that we are the publishers and no longer live in a permission-based system of launching ideas to the world.

We just need to remember that there’s a big medical world and a whole lot of eyeballs beyond our Twitter space. Let’s put our brilliance in the right place.

One Reply to “Rise of the Tweetorial”

Comments are closed.